Genmab says net sales of DARZALEX in 2024 totalled $11.67B
- Genmab A/S (GMAB) Wednesday reported that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous product, as reported by J&J were $11,670 million in 2024.
- Net trade sales were $6,588 million in the U.S. and $5,082 million in the rest